CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹34 Cr | ₹28 Cr | ₹23 Cr | ₹21 Cr | ₹17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CONCORD BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹34 Cr |
Mar2024 | ₹28 Cr |
Mar2023 | ₹23 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹17 Cr |
How is Deferred Tax Assets / Liabilities of CONCORD BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹34 Cr | 21.23 | |
Mar2024 | ₹28 Cr | 19.74 | |
Mar2023 | ₹23 Cr | 11.77 | |
Mar2022 | ₹21 Cr | 20.16 | |
Mar2021 | ₹17 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹16,954.1 Cr | -3% | -1% | -17.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,497.0 Cr | 1.1% | -1.9% | -14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,787.0 Cr | 1.1% | -0.6% | 10.4% | Stock Analytics | |
CIPLA | ₹125,870.0 Cr | -0.4% | -0.4% | -6.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,591.0 Cr | -1.7% | -2.5% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,380.0 Cr | 0.5% | 4.1% | -2.7% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -3% |
-1% |
-17.3% |
SENSEX | 1.6% |
2.3% |
1.1% |
You may also like the below Video Courses